Prednisolone Sodium Succinate

5 trials 3 recruiting HEndocrinology

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

3 Recruiting

1 Completed trials

5 Sponsors

22 Countries

Phase III

Phase II/III

Phase III: 4 Phase II/III: 1

Oversight events:

5 serious breaches 4 temporary halts 1 urgent safety measure across 4 trials

View oversight register →

Indications tested

Epidermolysis bullosa 1

Sponsors using this IMP

Charite Universitaetsmedizin Berlin KöR 1 Karolinska University Hospital 1 Medical University Of Silesia Katowice Poland 1 Prinses Maxima Centrum voor Kinderoncologie B.V. 1 Rheacell GmbH & Co. KG 1

All trials

5 total

IntReALL BCP 2020 – International Study for Treatment of Childhood Relapsed Precursor B-cell ALL 2020 Pending

2023-509392-17-00 Phase III 11 countries Charite Universitaetsmedizin Berlin KöR
Phase III clinical trial of ABCB5+ MSCs for the treatment of EB Recruiting

2022-500266-10-00 Phase III 12 countries Rheacell GmbH & Co. KG
CHIP-AML22 Master protocol: Protocol for the treatment of children and adolescents with Acute Myeloid Leukemia (AML) Recruiting

2023-504999-25-00 Phase III 12 countries Prinses Maxima Centrum voor Kinderoncologie B.V.
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia Recruiting

2022-501050-11-01 Phase II/III 14 countries Karolinska University Hospital
AIEOP-BFM 2017 POLAND - Collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia - A randomized phas… Ended

2024-517253-27-00 Phase III 1 country Medical University Of Silesia Katowice Poland

Showing 1–5 of 5 trials

← All drugs A–Z